Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...
CHMP issues positive recommendation for approval of lecanemab in the EU
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai ...
Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early Alzheimer's ...
Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...
Eisai receives positive CHMP opinion for Lecanemab in early Alzheimer’s disease
Eisai (ESAIY) and Biogen (BIIB) announced that a positive opinion has been received from the Committee for Medicinal Products for Human Use of ...
Medical Xpress29 天
Melanoma cells use apolipoprotein E to evade ferroptosis, study finds
Patrizia Agostinis (VIB-KU Leuven) has found that melanoma cell populations protect themselves from a form of cell death called ferroptosis by secreting the lipoprotein apolipoprotein E (ApoE).
多肽COG 133 CAS:514200-66-9
COG 133作为一种多功能的肽片段，在调节脂质代谢、抗炎、神经保护以及影响神经递质受体功能等方面展现出潜在的治疗价值。其作为nAChR拮抗剂的特性也为神经系统疾病的治疗提供了新的思路和靶点。未来，COG ...
clinicaltrialsarena23 天
AAO 2024: Neurodegeneration marker apolipoprotein E is elevated in the serum of patients ...
Credit: Prostock-studio via Shutterstock. On 20 October, during the American Academy of Ophthalmology (AAO) conference in Chicago, US, Hani El Helwe, MD, research fellow in Ophthalmology, Institution ...
McKnight's Long-Term Care News2 天
Healthier midlife linked to better outcomes in those prone to brain diseases: study
The team determined genetic risk using polygenic risk scores for stroke and depression, and utilized Apolipoprotein E (APOE) ...